Related Experiment Video
Updated: Sep 11, 2026
Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
Published on: May 10, 2022
[Study of serum ferritin in a population of 3-month-old breast feeding children]
Insights
Serum ferritin levels in 3-month-old infants confirm iron kinetics and the benefits of breast-feeding. This research establishes a reference value for early iron deficiency diagnosis and monitoring.
Area of Science:
- Pediatric Nutrition
- Clinical Chemistry
- Iron Metabolism
Context:
- Assessing iron status in infants is crucial for healthy development.
- Understanding iron kinetics in early life informs nutritional guidelines.
- Radioimmunological methods provide accurate serum ferritin measurements.
Purpose:
- To evaluate serum ferritin levels in 3-month-old infants.
- To establish reference values for infant iron status.
- To highlight the role of serum ferritin in diagnosing iron deficiency.
Summary:
- Serum ferritin levels were measured in 30 three-month-old infants using a radioimmunological method.
- The average values align with known iron kinetics during the first months of life.
- Findings support the completeness of breast-feeding and the utility of serum ferritin as a diagnostic marker.
Impact:
- Provides a reference value for early diagnosis of iron deficiency syndromes in infants.
- Supports the importance of monitoring iron status through serum ferritin levels.
- Contributes to optimizing infant nutrition and health outcomes through early intervention.
Abstract:
The evaluation of serum ferritin level in a population of 30 three months old babies is made by the Authors following a radioimmunological method. The reckoned average values reflect exactly the wellknown elements of iron kinetics during the first months of life. The Authors underline that those values show how complete is breast-feeding; moreover they emphasize the importance of a referring value which, together with those already known in subjects of different ages, allows on early diagnosis of syndromes due to iron decrease and subsequent check-up after therapeutic trial.
